$MOLN
$4.51
+$0.16 (3.68%)
MOLECULAR PARTNERS AG
molecularpartners.comMolecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Financial Snapshot
Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$74.80M
Current Assets
2026 Q1
$82.93M
Current Liabilities
2026 Q1
$8.799M
Current Ratio
2026 Q1
942.47%
Total Assets
2026 Q1
$87.66M
Total Liabilities
2026 Q1
$19.21M
Book Value
2026 Q1
68.45M
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$66.21M
Loading...
